Literature DB >> 10984527

Heparin sequencing brings structure to the function of complex oligosaccharides.

M A Nugent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10984527      PMCID： PMC34039          DOI： 10.1073/pnas.97.19.10301

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  29 in total

1.  Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.

Authors:  U R Desai; M Petitou; I Björk; S T Olson
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

2.  Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans.

Authors:  A J Rhomberg; S Ernst; R Sasisekharan; K Biemann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Ex vivo evaluation of a Taylor-Couette flow, immobilized heparinase I device for clinical application.

Authors:  G A Ameer; G Barabino; R Sasisekharan; W Harmon; C L Cooney; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.

Authors:  T Toida; R E Hileman; A E Smith; P I Vlahova; R J Linhardt
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

5.  Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.

Authors:  D A Pye; R R Vives; J E Turnbull; P Hyde; J T Gallagher
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

6.  Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding.

Authors:  C J Dowd; C L Cooney; M A Nugent
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

7.  Oligosaccharide composition of heparin and low-molecular-weight heparins by capillary electrophoresis.

Authors:  U R Desai; H Wang; S A Ampofo; R J Linhardt
Journal:  Anal Biochem       Date:  1993-08-15       Impact factor: 3.365

8.  Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues.

Authors:  H Margalit; N Fischer; S A Ben-Sasson
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

9.  Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin.

Authors:  S Yamada; K Yoshida; M Sugiura; K Sugahara; K H Khoo; H R Morris; A Dell
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

10.  Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations.

Authors:  J Reiland; A C Rapraeger
Journal:  J Cell Sci       Date:  1993-08       Impact factor: 5.285
View more
  19 in total

Review 1.  Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

Authors:  R V Iozzo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  A computational approach for deciphering the organization of glycosaminoglycans.

Authors:  Jean L Spencer; Joel A Bernanke; Jo Ann Buczek-Thomas; Matthew A Nugent
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

3.  Discovery of an intrinsic tenase complex inhibitor: Pure nonasaccharide from fucosylated glycosaminoglycan.

Authors:  Longyan Zhao; Mingyi Wu; Chuang Xiao; Lian Yang; Lutan Zhou; Na Gao; Zi Li; Jun Chen; Jianchao Chen; Jikai Liu; Hongbo Qin; Jinhua Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

4.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

5.  Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.

Authors:  Madelane Teran; Matthew A Nugent
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

6.  Scientific considerations in the review and approval of generic enoxaparin in the United States.

Authors:  Sau Lee; Andre Raw; Lawrence Yu; Robert Lionberger; Naiqi Ya; Daniela Verthelyi; Amy Rosenberg; Steve Kozlowski; Keith Webber; Janet Woodcock
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

Review 7.  Heparan sulfate-protein binding specificity.

Authors:  M A Nugent; J Zaia; J L Spencer
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

8.  Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow.

Authors:  Gregory O Staples; Hicham Naimy; Hongfeng Yin; Kevin Kileen; Karsten Kraiczek; Catherine E Costello; Joseph Zaia
Journal:  Anal Chem       Date:  2010-01-15       Impact factor: 6.986

9.  Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.

Authors:  Martin D Rees; John M Whitelock; Ernst Malle; Christine Y Chuang; Renato V Iozzo; Anastasia Nilasaroya; Michael J Davies
Journal:  Matrix Biol       Date:  2009-09-27       Impact factor: 11.583

10.  Control of growth factor networks by heparan sulfate proteoglycans.

Authors:  Kimberly Forsten-Williams; Chia Lin Chu; Michael Fannon; Jo Ann Buczek-Thomas; Matthew A Nugent
Journal:  Ann Biomed Eng       Date:  2008-10-07       Impact factor: 3.934
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.